Century Therapeutics

(NASDAQ) IPSC

Current Price$2.35

Market Cap$421.33M

Since IPO (2021)-90%

5 YearN/A

1 Year+352%

1 Month-10%

Century Therapeutics Financials at a Glance

Market Cap

$421.33M

Revenue (TTM)

$0.00

Net Income (TTM)

$107.78M

EPS (TTM)

$-1.11

P/E Ratio

-2.11

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$2.35

Volume

751,262.955

Open

$2.31

Price

$2.35

Volume

751,262.955

Open

$2.31

Previous Close

$2.34

Daily Range

$2.24 - $2.35

52-Week Range

$0.43 - $3.04

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$2.35

Volume

751,262.955

Open

$2.31

Previous Close

$2.34

Daily Range

$2.24 - $2.35

52-Week Range

$0.43 - $3.04

IPSC News

Century Reports Flat Loss in Fiscal Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Century Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Brent Pfeiffenberger, PharmD

Website

www.centurytx.com

Headquarters

Philadelphia, PA 19104, US

IPSC Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-43%

Return on Capital

-37%

Return on Assets

-33%

Earnings Yield

-47.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$421.33M

Shares Outstanding

180.06M

Volume

751.26K

Avg. Volume

1.18M

Financials (TTM)

Gross Profit

$96.06M

Operating Income

$15.04M

EBITDA

$1.94M

Operating Cash Flow

$103.88M

Capital Expenditure

$848.00K

Free Cash Flow

$104.72M

Cash & ST Invst.

$117.11M

Total Debt

$43.56M

Century Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$3.00M

-102.8%

Gross Margin

0.00%

N/A

Market Cap

$421.33M

N/A

Market Cap/Employee

$3.01M

N/A

Employees

140

N/A

Net Income

$21.64M

-128.3%

EBITDA

$22.50M

-129.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$90.86M

-19.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$43.94M

-8.1%

Short Term Debt

$0.00

-100.0%

Return on Assets

-33.01%

N/A

Return on Invested Capital

-37.36%

N/A

Free Cash Flow

$25.83M

+25.4%

Operating Cash Flow

$25.24M

+27.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EQEquillium, Inc.

EQEquillium, Inc.$2.18-15.83%

KPTIKaryopharm Therapeutics Inc.

KPTIKaryopharm Therapeutics Inc.$7.67-13.82%

CUECue Biopharma, Inc.

CUECue Biopharma, Inc.$23.01-9.16%

COEPCoeptis Therapeutics, Inc.

COEPCoeptis Therapeutics, Inc.$16.40+0.00%

TELOTelomir Pharmaceuticals, Inc. Common Stock

TELOTelomir Pharmaceuticals, Inc. Common Stock$1.26-0.79%

SNTISenti Biosciences, Inc.

SNTISenti Biosciences, Inc.$1.01-2.88%

GNTAGenenta Science S.p.A.

GNTAGenenta Science S.p.A.$0.63-0.32%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

INTCIntel

INTCIntel$108.77-0.06%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

FIGFigma

FIGFigma$22.92+0.13%

Questions About IPSC

What is the current price of Century Therapeutics?

Century Therapeutics is trading at $2.34 per share.

What is the 52-week range for Century Therapeutics?

Over the past 52 weeks, Century Therapeutics has traded between $0.44 and $3.04.

How much debt does Century Therapeutics have?

As of the most recent reporting period, Century Therapeutics reported total debt of $48.02M.

How much cash does Century Therapeutics have on hand?

Century Therapeutics reported $51.40M in cash and cash equivalents in its most recent financial results.

What is Century Therapeutics’s dividend yield?

Century Therapeutics does not currently have a dividend yield.

Century Therapeutics

Century Therapeutics Financials at a Glance

IPSC News

Century Reports Flat Loss in Fiscal Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Century Therapeutics

IPSC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Century Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IPSC

What is the current price of Century Therapeutics?

What is the 52-week range for Century Therapeutics?

How much debt does Century Therapeutics have?

How much cash does Century Therapeutics have on hand?

What is Century Therapeutics’s dividend yield?

Premium Investing Services